Vitrology’s management team members have played pivotal roles in the global biosafety testing sector since the early 1990s. At our GLP / cGMP facility we are providing testing solutions in the areas of:
 |
Cell Line Characterisation to International Regulatory Standards |
|
In-Process Material Testing |
|
cGMP Bulk Harvest Lot Releasing Testing |
|
Final Product Testing of Proteins, Monoclonal Antibodies, Virus/Bacterial Vaccine & Cell Therapies. |
|
QC Assay Development/Validation & Technology Transfer to Clients. |
|
Human “Swine“ flu and vaccine Testing
1st May 2009
As with other biologics, adventitious viral agents pose a significant risk to any cell culture influenza vaccine production process, as will be the case with Swine flu vaccine.
Click
for more |
|
|
 |
|
| Exceptional service levels, the goal of Vitrology, requires among many priorities, clear, concise, transparent, and on demand, communication with our clients. The Vitrology Bionet will deliver all this and more. Click on the button above for more information. |
|
|
|
